# FDA Inspection 1298600 - Nanophase Technologies Corporation - January 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/2f9779b0-d2b3-449c-aea2-02771d6ab0b8
Source feed: FDA_Inspections

> FDA Inspection 1298600 for Nanophase Technologies Corporation on January 09, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298600
- Company Name: Nanophase Technologies Corporation
- Inspection Date: 2026-01-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1298600 - 2026-01-09](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/15d88410-e532-46d7-80a1-b982caf658e5)
- [FDA Inspection 1205286 - 2023-04-13](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/22d2e70e-237e-4e93-9811-df1e87ad4563)
- [FDA Inspection 1096141 - 2019-06-07](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/395a0561-ea51-4c80-9bb9-b048f6253d4b)
- [FDA Inspection 896947 - 2014-09-15](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/833968bc-ab05-4cad-bf45-9281888fac5f)
- [FDA Inspection 896947 - 2014-09-15](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/bc2ad1a6-d733-419b-bfec-fa0c64f23ae2)

Company: https://www.keypedia.com/companies/nanophase-technologies-corporation/2b2b4bbe-7d35-4ece-8a79-dbffc6f82a51